Pemberton Greenish and Cripps merge targeting real estate, private wealth and growing businesses

Leading South East firm Cripps and London firm Pemberton Greenish will merge on 1 December to create a leading practice focusing on real estate, private wealth and growing businesses. The merged firm will be ranked in the top 70 of UK law firms with revenues of c£45 million and create a firm of 465 people, including 66 partners.

The new firm, which will trade as Cripps Pemberton Greenish, aims to provide the full range of skills across commercial, real estate and private client law. The firm will expand its London offering while retaining Cripps’ presence in Kent.

Gavin Tyler, managing partner of Cripps, said: “It has been a key strategic objective for a number of years to significantly develop our London business. By merging with Pemberton Greenish we will be able to take a joint step forward to deliver a broader, deeper, and even more personal service to all our clients. Being headquartered in Kent however remains a key part of who we are, the clients we want to work with and why Cripps is the firm it is.”

Kerry Glanville, senior partner of Pemberton Greenish, added: “We’re thrilled to join forces with Cripps. Our clients will benefit from our much-increased breadth of service and fully developed infrastructure that modern legal businesses require to be successful. Together we’ll be a true force.”

Get the LCN Weekly newsletter

Get our news, features, recruiter and lawyer interviews, burning questions, blog posts and more sent straight to your inbox with our weekly newsletter. You also get access to a free personal MyLCN account.

Sign up to LawCareers.Net to receive the LCN Weekly newsletter, diary updates, events, surveys and other emails providing information for future lawyers. Please note that we ask you to provide a password so that you can access MyLCN and edit your subscriber details, including email preferences.

 

Data Protection
To see how we use your data, please visit the Privacy Policy.

 

Terms
This subscription is subject to our Terms & Conditions.

Comment

Sign in to MyLCN to have your say.